Phibro Animal Health Corp's fundamentals are relatively stable, with industry-average ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 30 out of 159 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 43.00.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Phibro Animal Health Corp's Score
Industry at a Glance
Industry Ranking
30 / 159
Overall Ranking
103 / 4555
Industry
Pharmaceuticals
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
Phibro Animal Health Corp Highlights
StrengthsRisks
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 32.55% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.30B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 40.30%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 40.30%.
Fairly Valued
The company’s latest PE is 23.94, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 20.39M shares, decreasing 13.27% quarter-over-quarter.
Phibro Animal Health Corporation is a global diversified animal health and mineral nutrition company. It develops, manufactures and markets a range of products for food and companion animals, including poultry, swine, beef and dairy cattle, aquaculture and dogs. It markets approximately 750 product lines in over 80 countries to approximately 4,200 customers. It has three segments: Animal Health, Mineral Nutrition and Performance Products. Its Animal Health segment develops, manufactures and markets about 280 product lines, including antibacterials, anticoccidials and related products; nutritional specialty products; and vaccines. The Mineral Nutrition segment is comprised of formulations and concentrations of trace minerals such as zinc, manganese, copper, iron and other compounds, with a focus on customers in North America. The Performance Products segment manufactures and markets specialty ingredients for use in the personal care, industrial chemical and chemical catalyst industries.
Ticker SymbolPAHC
CompanyPhibro Animal Health Corp
CEOBendheim (Jack C)
Websitehttps://www.pahc.com/
FAQs
What is the current price of Phibro Animal Health Corp (PAHC)?
The current price of Phibro Animal Health Corp (PAHC) is 40.060.
What is the symbol of Phibro Animal Health Corp?
The ticker symbol of Phibro Animal Health Corp is PAHC.
What is the 52-week high of Phibro Animal Health Corp?
The 52-week high of Phibro Animal Health Corp is 46.420.
What is the 52-week low of Phibro Animal Health Corp?
The 52-week low of Phibro Animal Health Corp is 16.160.
What is the market capitalization of Phibro Animal Health Corp?
The market capitalization of Phibro Animal Health Corp is 1.62B.
What is the net income of Phibro Animal Health Corp?
The net income of Phibro Animal Health Corp is 48.26M.
Is Phibro Animal Health Corp (PAHC) currently rated as Buy, Hold, or Sell?
According to analysts, Phibro Animal Health Corp (PAHC) has an overall rating of Hold, with a price target of 43.000.
What is the Earnings Per Share (EPS TTM) of Phibro Animal Health Corp (PAHC)?
The Earnings Per Share (EPS TTM) of Phibro Animal Health Corp (PAHC) is 1.673.